Search research articles
Contact Us
Filters
Showing results (711-720 of 714) with videos related to
Page
of 72
Sort By:
You have reached the last page of results.
This site can display upto 714 results.
Familial Cancer
|
September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
H F A Vasen, G Möslein, A Alonso, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Plos One
|
July 23, 2011
Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood
Unnur S Bjornsdottir, Stephen T Holgate, Padmalatha S Reddy, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial
Mark J Mulligan, David I Bernstein, Sharon Frey, et al.
Page
of 72
Search research articles
Search
Showing results (711-720 of 714) with videos related to
Sort By:
Page
of 72
You have reached the last page of results.
This site can display upto 714 results.
Familial Cancer
|
September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
H F A Vasen, G Möslein, A Alonso, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Plos One
|
July 23, 2011
Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood
Unnur S Bjornsdottir, Stephen T Holgate, Padmalatha S Reddy, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial
Mark J Mulligan, David I Bernstein, Sharon Frey, et al.
Page
of 72